EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 308 filers reported holding EXELIXIS INC in Q2 2018. The put-call ratio across all filers is 0.32 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $267,000 | -7.3% | 15,225 | -6.2% | 0.00% | 0.0% |
| Q3 2019 | $288,000 | -21.1% | 16,225 | -4.8% | 0.00% | -33.3% |
| Q2 2019 | $365,000 | -7.8% | 17,049 | +2.3% | 0.00% | 0.0% |
| Q1 2019 | $396,000 | +158.8% | 16,670 | +114.0% | 0.00% | +50.0% |
| Q4 2018 | $153,000 | +39.1% | 7,791 | +25.4% | 0.00% | +100.0% |
| Q3 2018 | $110,000 | +3.8% | 6,215 | +25.5% | 0.00% | 0.0% |
| Q2 2018 | $106,000 | -10.9% | 4,954 | -6.8% | 0.00% | -50.0% |
| Q1 2018 | $119,000 | -78.4% | 5,318 | -70.7% | 0.00% | -71.4% |
| Q4 2017 | $552,000 | +34.6% | 18,134 | +7.1% | 0.01% | +16.7% |
| Q3 2017 | $410,000 | -2.1% | 16,933 | -0.7% | 0.01% | -14.3% |
| Q2 2017 | $419,000 | +43.0% | 17,056 | +25.9% | 0.01% | +16.7% |
| Q1 2017 | $293,000 | +22.6% | 13,550 | -15.7% | 0.01% | +20.0% |
| Q4 2016 | $239,000 | +32.8% | 16,083 | +14.3% | 0.01% | +25.0% |
| Q3 2016 | $180,000 | +17.6% | 14,072 | -28.7% | 0.00% | 0.0% |
| Q2 2016 | $153,000 | – | 19,743 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 15,001,073 | $199,507,000 | 56.91% |
| Sargent Investment Group, LLC | 1,032,560 | $18,193,000 | 3.40% |
| Bellevue Group AG | 3,930,700 | $69,259,000 | 1.10% |
| CAPITAL MANAGEMENT CORP /VA | 231,880 | $4,086,000 | 1.04% |
| Orbimed Advisors | 3,753,700 | $66,140,000 | 0.94% |
| TEALWOOD ASSET MANAGEMENT INC | 121,848 | $2,147,000 | 0.90% |
| FARALLON CAPITAL MANAGEMENT LLC | 7,500,000 | $132,150,000 | 0.89% |
| Chicago Capital, LLC | 806,113 | $14,204,000 | 0.87% |
| Penn Capital Management Company, LLC | 456,587 | $8,045,000 | 0.84% |
| AJO, LP | 7,636,882 | $134,561,000 | 0.80% |